Biological Effects of Anti-RANKL Antibody and Zoledronic Acid on Growth and Tooth Eruption in Growing Mice

The anti-bone resorptive drugs denosumab, an anti-human-RANKL antibody, and zoledronic acid (ZOL), a nitrogen-containing bisphosphonate, have recently been applied for treatment of pediatric patients with bone diseases, though details regarding their effects in growing children have yet to be fully...

Full description

Saved in:
Bibliographic Details
Published in:Sci Rep
Main Authors: Isawa, Motoki, Karakawa, Akiko, Sakai, Nobuhiro, Nishina, Saki, Kuritani, Miku, Chatani, Masahiro, Negishi-Koga, Takako, Sato, Masashi, Inoue, Mitsuko, Shimada, Yukie, Takami, Masamichi
Format: Artigo
Language:Inglês
Published: Nature Publishing Group UK 2019
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6934544/
https://ncbi.nlm.nih.gov/pubmed/31882595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-56151-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items